natgillin/translations-raw huggingface dataset:
The safety of sevelamer (as either carbonate and hydrochloride salts) has been investigated in numerous clinical trials involving a total of 969 haemodialysis patients with treatment duration of 4 to 50 weeks (724 patients treated with sevelamer hydrochloride and 245 with sevelamer carbonate), 97 peritoneal dialysis patients with treatment duration of 12 weeks (all treated with sevelamer hydrochloride) and 128 patients with CKD not on dialysis with treatment duration of 8 to 12 weeks (79 patients treatment with sevelamer hydrochloride and 49 with sevelamer carbonate). 
Varnost sevelamera (bodisi kot karbonata in kloridne soli) je bila raziskana v številnih kliničnih preskušanjih, ki so zajela skupaj 969 bolnikov na hemodializi, pri katerih je zdravljenje trajalo med 4 do 50 tednov (724 bolnikov, zdravljenih s sevelamerijevim kloridom in 245 s sevelamerijevim karbonatom), 97 bolnikov na peritonealni dializi, pri katerih je zdravljenje trajalo 12 tednov (vsi zdravljeni s sevelamerijevim kloridom) in 128 bolnikih s KBL, ki niso na dializi, pri katerih je zdravljenje trajalo med 8 do 12 tednov (79 bolnikov, zdravljenih s sevelamerijevim kloridom, in 49 s sevelamerijevim karbonatom).
Each sachet of 2.4 g of powder is to be dispersed in 60 ml of water prior to administration (see section 6.6). 
Vsako vrečico po 2,4 g praška je treba pred uporabo raztopiti v 60 ml vode (glejte poglavje 6.6).
Sevelamer carbonate Winthrop powder should not be heated (e.g. microwave) or added to heated foods or liquids. 
Praška zdravila Sevelamerijev karbonat Winthrop naj se ne segreva (npr. mikrovalovna pečica) ali dodaja v ogreto hrano ali tekočino.
The most frequently occurring (≥5% of patients) adverse reactions were all in the gastrointestinal disorders system organ class: nausea (very common), vomiting (very common), upper abdominal pain (very common), constipation (very common), diarrhea (common), dyspepsia (common) and flatulence (common). 
Najpogostejši neželeni učinki (≥ 5 % bolnikov) so bili vsi v organskem sistemu bolezni prebavil: navzea (zelo pogosti), bruhanje (zelo pogosti), bolečine v zgornjem delu trebuha (zelo pogosti), zaprtost (zelo pogosti), diareja (pogosti), dispepsija (pogosti) in flatulenca (pogosti).
• Medicines treating heartburn and reflux from your stomach or oesophagus, such as omeprazole, pantoprazole, or lansoprazole, known as “proton pump inhibitors”, may reduce the efficacy of Sevelamer carbonate Winthrop. 
• Zdravila za zdravljenje zgage in vračanja kisline (refluksa) iz želodca ali požiralnika, ki jih imenujemo "zaviralci protonske črpalke" in med katere spadajo na primer omeprazol, pantoprazol in lansoprazol, lahko zmanjšajo učinkovitost zdravila Sevelamerijev karbonat Winthrop.
The recommended starting dose of Sevelamer carbonate Winthrop for children is based on their height and weight (used to calculate body surface area by your physician). 
Priporočeni začetni odmerek zdravila Sevelamerijev karbonat Winthrop za otroke temelji na njihovi telesni višini in telesni masi (ta dva podatka zdravnik uporabi za izračun telesne površine).
Sevelamer hydrochloride, which contains the same active moiety as sevelamer carbonate, has been given to normal healthy volunteers in doses of up to 14 grams per day for eight days with no adverse reactions. 
Sevelamerijev klorid, ki vsebuje enako učinkovino kot sevelamerijev karbonat, so dajali zdravim prostovoljcem v odmerkih do 14 gramov na dan za osem dni brez pojava neželenih učinkov.
• major gastrointestinal tract surgery 
• velika operacija gastrointestinalnega trakta
Deficits in skeletal ossification were observed in several locations in foetuses of female rats dosed with sevelamer at intermediate and high doses (human equivalent dose less than the maximum clinical trial dose of 14.4 g). 
Primanjkljaje skeletalne osifikacije so opazili na več mestih pri fetusu podganjih samic s srednjimi in visokimi odmerki sevelamera (primerjalni odmerek pri človeku je manj kot je največji odmerek v kliničnem preskušanju, ki je 14,4 g).
Do not heat Sevelamer carbonate Winthrop powder (e.g. microwave) or add to hot foods or liquids. 
Praška zdravila Sevelamerijev karbonat Winthrop ne segrevajte (npr. mikrovalovna pečica) ali dodajte v vročo hrano ali tekočino.
Studies in animals have shown that sevelamer did not impair fertility in male or female rats at exposures at a human equivalent dose 2 times the maximum clinical trial dose of 13 g/day, based on a comparison of relative BSA. 
Študije na živalih so pokazale, da sevelamer ne vpliva na plodnost pri samcih in samičkah podgan pri izpostavljenosti primerjalnemu odmerku pri človeku, dvakrat večjemu od največjega odmerka pri kliničnem preskušanju 13 g/dan, na osnovi relativne površine telesa.
In some cases where Sevelamer carbonate Winthrop should be taken at the same time as another medicine, your doctor may advise you to take this medicine 1 hour before or 3 hours after Sevelamer carbonate Winthrop intake. 
V nekaterih primerih, ko je treba zdravilo Sevelamerijev karbonat Winthrop vzeti sočasno z drugim zdravilom, vam bo zdravnik morda svetoval, da vzamete drugo zdravilo 1 uro pred ali 3 ure po vnosu zdravila Sevelamer carbonate Winthrop.
180 film-coated tablets 
FARMACEVTSKA OBLIKA IN VSEBINA 180 filmsko obloženih tablet
Patients with CKD may develop hypocalcaemia or hypercalcaemia. 
Pri bolnikih s KBL lahko pride do hipokalcemije ali hiperkalcemije..
Constipation can be an early symptom of serious gastrointestinal adverse reactions. 
Zaprtost je lahko zgodnji znak hudih neželenih učinkov v prebavilih.
Sevelamer carbonate Winthrop is unlikely to affect your ability to drive or to use machines. 
Ni verjetno, da bi zdravilo Sevelamerijev karbonat Winthrop vplivalo na vašo sposobnost vožnje in upravljanja strojev.
Initially, your doctor will check the levels of phosphorus in your blood every 2-4 weeks and may adjust the dose of Sevelamer carbonate Winthrop when necessary to reach an adequate phosphate level. 
Vaš zdravnik bo na začetku zdravljenja vsake 2 - 4 tedne preverjal ravni fosforja v vaši krvi in po potrebi prilagodil odmerek zdravila Sevelamer carbonate Winthrop, če bo to treba zaradi doseganja ustrezne ravni fosfata.
• if you have swallowing problems. 
• če imate težave s požiranjem.
(Instructions for presentation with dosing spoon) The sachet has to be discarded after 24 hours of opening 
(Navodila za obliko z odmerno žličko) Zavrzite vrečico v roku 24 ur po odprtju.
In pregnant rabbits given oral doses of sevelamer hydrochloride by gavage during organogenesis, an increase of early resorptions occurred in the high-dose group (human equivalent dose twice the maximum clinical trial dose). 
Pri brejih kunčjih samicah, ki so dobivale peroralne odmerke sevelamerijevega klorida z gavažo v času organogeneze, je prišlo do zgodnje resorpcije v skupini, ki je dobivala visoke odmerke (primerjalni odmerek pri človeku je dvakrat večji od največjega odmerka v kliničnem preskušanju).
• severe gastrointestinal motility disorders including untreated or severe gastroparesis, retention of gastric contents and abnormal or irregular bowel motion 
• hude motnje gastrointestinalnega gibanja vključno z nezdravljeno ali hudo gastroparezo, zadrževanjem vsebine v želodcu in nenormalnim ali nerednim gibanjem črevesa
Cases of serious inflammatory disorders of different parts of the gastrointestinal tract (including serious complications such as haemorrhage, perforation, ulceration, necrosis, colitis and colonic/caecal mass) associated with the presence of sevelamer crystals have been reported (see section 4.8). 
V literaturi so bili opisani primeri resnih vnetnih bolezni različnih delov prebavil (vključno z resnimi zapleti, kot so npr. krvavitev, perforacija, ulceracija, nekroza, kolitis in masa v debelem črevesu/cekuumu), povezanih s prisotnostjo kristalov sevelamerja (glejte poglavje 4.8).
• Hypophosphataemia. 
• hipofosfatemija
Each film-coated tablet contains 800 mg of sevelamer carbonate. 
Vsaka filmsko obložena tableta vsebuje 800 mg sevelamerijevega karbonata.
This medicine does not require any special storage conditions. 
To zdravilo ne potrebuje posebnih pogojev shranjevanja.
What Sevelamer carbonate Winthrop is and what it is used for 
Kaj je zdravilo Sevelamerijev karbonat Winthrop in za kaj ga uporabljamo
For patients previously on phosphate binders (sevelamer hydrochloride or calcium based), Sevelamer carbonate Winthrop should be given on a gram for gram basis with monitoring of serum phosphorus levels to ensure optimal daily doses. 
Bolnikom, ki so prej uživali vezalce fosforja (sevelamerijev klorid ali kalcijev sevelamerat), je treba zdravilo Sevelamerijev karbonat Winthrop dajati na osnovi gram po gram ter pri tem nadzirati ravni fosforja v serumu, da se zagotovijo optimalni dnevni odmerki.
The treatment response during the 2-week FDP was not affected by BSA, in contrast however, no treatment response was observed in pediatric patients with qualifying phosphorus levels <7.0 mg/dL. 
Telesna površina ni vplivala na odziv na zdravljenje med 2-tedenskim UFO, niso pa opazili nobenega odziva pri pediatričnih bolnikih s kvalifikacijsko koncentracijo fosforja < 7,0 mg/dl.
Sevelamer carbonate Winthrop is indicated for the control of hyperphosphataemia in adult patients receiving haemodialysis or peritoneal dialysis. 
Zdravilo Sevelamerijev karbonat Winthrop je indicirano za nadzor hiperfosfatemije pri odraslih bolnikih, ki prejemajo hemodializo ali peritonealno dializo.
In case of constipation, please inform your doctor or pharmacist if you experience it. 
V primeru zaprtosti o tem obvestite svojega zdravnika ali farmacevta.
Sevelamer hydrochloride did not impair the fertility of male or female rats in a dietary administration study in which the females were treated from 14 days prior to mating through gestation and the males were treated for 28 days prior to mating. 
Sevelamerijev klorid ni okvaril sposobnosti razmnoževanja podganjih samcev ali samic v študiji z dietnim odmerjanjem, v kateri so bile samice obravnavane 14 dni pred parjenjem in ves čas brejosti, samci pa 28 dni pred parjenjem.
In two randomised, cross over clinical trials, sevelamer carbonate has been shown to be therapeutically equivalent to sevelamer hydrochloride and therefore effective in controlling serum phosphorus in CKD patients on haemodialysis. 
V dveh randomiziranih, navzkrižnih kliničnih študijah se je sevelamerijev karbonat pokazal kot terapevtsko enakovreden s sevelamerijevim kloridom in zato učinkovit pri nadziranju fosforja v serumu pri bolnikih s KBL na hemodializi.
Your doctor will check for interactions between Sevelamer carbonate Winthrop and other medicines on a regular basis. 
Sevelamerijev karbonat Winthrop Zdravnik bo redno preverjal medsebojno delovanje zdravila Sevelamerijev karbonat Winthrop in ostalih zdravil.
Constipation is a very common side effect. 
Zaprtost je zelo pogosti neželeni učinek.
These symptoms can be due to serious inflammatory bowel disease caused by sevelamer crystal deposit in your bowel. 
Ti simptomi so lahko posledica odlaganja kristalov sevelamerja v črevesju.
There was no increased incidence of tumors observed in mice (human equivalent dose 3 times the maximum clinical trial dose). 
Pri miših niso opazili povečanja pojavnosti tumorjev (primerjalni odmerek pri človeku 3-krat večji od največjega odmerka v kliničnem preskušanju).
In this case the 0.4 g dose of Sevelamer Carbonate Winthrop powder must be measured using the dosing spoon provided in the carton. 
V tem primeru je treba 0,4 g odmerek zdravila Sevelamerijev karbonat Winthrop odmeriti z odmerno žličko, ki se nahaja v škatli.
In two randomised, cross over clinical trials, sevelamer carbonate in both tablet and powder formulations when administered three times per day has been shown to be therapeutically equivalent to sevelamer hydrochloride and therefore effective in controlling serum phosphorus in CKD patients on haemodialysis. 
V dveh randomiziranih, navzkrižnih kliničnih študijah se je pri bolnikih, ki so dobivali sevelamerijev karbonat v obliki tablete in praška trikrat na dan, pokazal kot terapevtsko enakovreden s sevelamerijevim kloridom in zato učinkovit pri nadziranju fosforja v serumu pri bolnikih s KBL na hemodializi.
What Sevelamer carbonate Winthrop looks like and contents of the pack 
Izgled zdravila Sevelamerijev karbonat Winthrop in vsebina pakiranja
Talk to your doctor who will decide if you can continue the treatment with Sevelamer carbonate Winthrop. 
Posvetujte se s svojim zdravnikom, ki bo presodil, ali lahko nadaljujete zdravljenje z zdravilom Sevelamer carbonate Winthrop.
The tablets are packed in high density polyethylene bottles with a child-resistant polypropylene closure and an induction seal. 
Tablete so pakirane v polietilenske plastenke visoke gostote z za otroke varnim polipropilenskim pokrovom in induktivno zvarjeno zaporko.
To achieve the correct dose when the sachet has to be divided, please use the dedicated presentation of 0.8 g powder with dosing spoon. 
Za dosego ustreznega odmerka, ko je treba vrečico razdeliti, prosimo uporabite temu namenjeno 0,8 g obliko praška z odmerno žličko.
Taking your Sevelamer carbonate Winthrop treatment is important to maintain an appropriate phosphate level in your blood. 
Če ste prenehali jemati zdravilo Sevelamerijev karbonat Winthrop Jemanje zdravila Sevelamerijev karbonat Winthrop je pomembno za vzdrževanje ustrezne koncentracije fosfata v krvi.
Sevelamer carbonate Winthrop is indicated for the control of hyperphosphataemia in paediatric patients (>6 years of age and a body surface area (BSA) of >0.75 m2) with chronic kidney disease. 
Zdravilo Sevelamerijev karbonat Winthrop je indicirano za obvladovanje hiperfosfatemije pri pediatričnih bolnikih (starih > 6 let in s telesno površino > 0,75 m2) s kronično boleznijo ledvic.
Sevelamer carbonate Winthrop powder for oral suspension is a pale yellow powder supplied in a foil sachet with a heat seal. 
Sevelamerijev karbonat Winthrop prašek za peroralno suspenzijo je svetlorumeni prašek, na voljo v termično zvarjeni vrečici iz folije.
Sevelamer carbonate Winthrop must be taken three times per day with meals or snacks. 
Zdravilo Sevelamerijev karbonat Winthrop je treba jemati trikrat na dan z obroki ali prigrizki.
• if you have undergone major surgery on your stomach or bowel. 
• če ste imeli veliko operacijo trebuha ali črevesa.
Sevelamer carbonate treatment should be reevaluated in patients who develop severe constipation or other severe gastrointestinal symptoms. 
Zdravljenje z zdravilom Sevelamerijev karbonat Winthrop je treba znova oceniti pri bolnikih, ki se jim pojavijo huda zaprtost ali kakšni drugi hudi gastrointestinalni simptomi.
Sevelamer carbonate Winthrop must be taken three times per day with meals. 
Zdravilo Sevelamerijev karbonat Winthrop je treba jemati trikrat dnevno z obroki.
The anti-arrhythmic medical product should be taken at least one hour before or three hours after Sevelamer carbonate Winthrop, and blood monitoring can be considered. 
Antiaritmik mora bolnik vzeti vsaj eno uro pred zdravilom Sevelamerijev karbonat Winthrop ali tri ure po njem; lahko se razmisli o pregledih krvi.
What you need to know before you take Sevelamer carbonate Winthrop 3. 
Kaj morate vedeti, preden boste vzeli zdravilo Sevelamer carbonate Winthrop 3.
Patients who are constipated should be monitored carefully while being treated with sevelamer carbonate. 
Zaprte bolnike je potrebno med zdravljenjem z sevelamerjevim karbonatom skrbno nadzorovati.
PARTICULARS TO APPEAR ON THE OUTER PACKAGING OUTER CARTON - BOTTLE OF 30 TABLETS 
PODATKI NA ZUNANJI OVOJNINI ŠKATLA - STEKLENIČKA S 30 TABLETAMI
There was an increased incidence of urinary bladder transitional cell papilloma in male rats of the high dose group (human equivalent dose twice the maximum clinical trial dose of 14.4 g). 
Opazili so večjo pojavnost papiloma tranzicijskih celic mehurja pri podganjih samcih v skupini z visokimi odmerki (primerjalni odmerek pri človeku je dvakrat večji od največjega odmerka v kliničnem preskušanju, ki je 14,4 g).
MedDRA System 
Organski sistem po MedDRA
The white to off-white tablets are imprinted with “SC800” on one side. 
FARMACEVTSKA OBLIKA filmsko obložena tableta (tableta) Bele do sivo-bele tablete z natisom „SC800“ na eni strani.
The study met its primary endpoint, meaning sevelamer carbonate reduced serum phosphorus by an LS mean difference of 0.90 mg/dL compared to placebo, and secondary efficacy endpoints. 
Študija je dosegla svoj primarni opazovani dogodek: to pomeni, da je sevelamerijev karbonat v primerjavi s placebom znižal koncentracijo fosforja v serumu za povprečno 0,90 mg/dl (po metodi najmanjših kvadratov); dosegla je tudi sekundarne opazovane dogodke učinkovitosti.
For a 2.4 g dose, the powder for oral suspension should be dispersed in 60 ml of water per sachet. 
2,4 g praška za peroralno suspenzijo raztopite v 60 ml vode na vrečico.
• Thyroid hormone deficiency may uncommonly be observed in certain people taking levothyroxine (used to treat low thyroid hormone levels) and Sevelamer carbonate Winthrop. 
• Pri nekaterih ljudeh, ki jemljejo levotiroksin (uporablja se za zdravljenje nizkih ravni tiroidnega hormona) in zdravilo Sevelamer carbonate Winthrop, so redko opazili pomanjkanje tiroidnega hormona.
• upper abdominal pain, 
• bolečine v zgornjem delu trebuha,
EU/1/14/952/001 180 film-coated tablets EU/1/14/952/004 30 film-coated tablets 
ŠTEVILKA(E) DOVOLJENJA (DOVOLJENJ) ZA PROMET Z ZDRAVILOM EU/1/14/952/001 180 filmsko obloženih tablet EU/1/14/952/004 30 filmsko obloženih tablet
HDPE bottles with a child resistant polypropylene closure and a foil induction seal. 
Plastenke HDPE z za otroke varnim polipropilenskim pokrovom in induktivno zvarjeno zaporko iz folije.
Talk to your doctor who will decide if you can breastfeed your baby or not, and if it is necessary to stop Sevelamer carbonate Winthrop treatment. 
Posvetujte se s svojim zdravnikom, ki bo presodil, ali otroka lahko dojite in ali morate prenehati zdravljenje z zdravilom Sevelamerijev karbonat Winthrop.
Powder for oral suspension 90 sachets 
FARMACEVTSKA OBLIKA IN VSEBINA prašek za peroralno suspenzijo 90 vrečic
Anti-arrhythmics and anti-seizure medicinal products 
Antiaritmiki in antiepileptična zdravila za nadzor epileptičnih napadov
Patients taking Sevelamer carbonate Winthrop should adhere to their prescribed diets. 
Bolniki, ki jemljejo sevelamerijev karbonat, morajo uživati predpisano dieto.
- Serious inflammation of the large bowel (symptoms include: severe abdominal pain, stomach or intestine disorders, or blood in the stool [gastrointestinal bleeding]) and crystal deposit in the intestine have been reported. 
- Poročali so o resnih vnetnih bolezni črevesa (znaki vključujejo: hudo bolečino v trebuhu, želodcu ali črevesu, ali kri v blatu (krvavitev v prebavilih) in kristalnih depozitih v črevesu.
Children and adolescents (>6 years of age and a BSA of >0.75m2) For paediatric patients, serum phosphorus levels must be monitored and the dose of sevelamer carbonate titrated in increments based on patient's BSA, three times per day every 2-4 weeks until an acceptable serum phosphorus level is reached, with regular monitoring thereafter. 
Otroci in mladostniki (stari > 6 let in s telesno površino > 0,75 m2) Pri pediatričnih bolnikih je treba koncentracijo fosforja v serumu kontrolirati in odmerek sevelamerijevega karbonata titrirati v povečanjih glede na bolnikovo telesno površino trikrat na dan vsaka 2 do 4 tedne, dokler ni dosežena sprejemljiva koncentracija fosforja v serumu; potem je treba koncentracijo redno kontrolirati.
• vomiting, 
• bruhanje,
Intestinal ulceration1, Gastrointestinal necrosis1, Colitis1, Intestinal mass1 
črevesna razjeda1, gastrointestinalna nekroza1, kolitis1, masa v črevesu1
The oral suspension must be administered within 30 minutes. 
Peroralno suspenzijo je treba uporabiti v 30 minutah.
The phosphate serum level should be monitored and the Sevelamer carbonate dosage adjusted consequently. 
Koncentracijo fosfata v serumu je treba kontrolirati in odmerjanje sevelamerijevega karbonata ustrezno prilagoditi.
PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGING LABEL - BOTTLE OF 180 TABLETS WITHOUT OUTER CARTON 
PODATKI NA STIČNI OZ. PRIMARNI OVOJNINI OZNAKA- STEKLENIČKA S 180 TABLETAMI BREZ ZUNANJE ŠKATLE
How to take Sevelamer carbonate Winthrop 4. 
Kako jemati zdravilo Sevelamer carbonate Winthrop 4.
• patients with chronic (long-term) kidney disease who are not on dialysis and have a serum (blood) phosphorus level equal to or above 1.78 mmol/L. 
• bolnikih s kroničnim (dolgotrajnim) obolenjem ledvic, ki niso na dializi in imajo serumske (krvne) ravni fosforja enake ali višje kot 1,78 mmol/l.
(Instructions for presentation with dosing spoon) 
(Navodila za obliko Z odmerno žličko)
Powder for oral suspension 60 sachets 
FARMACEVTSKA OBLIKA IN VSEBINA prašek za peroralno suspenzijo 60 vrečic
PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGING LABEL - BOTTLE OF 30 TABLETS 
PODATKI NA STIČNI OZ. PRIMARNI OVOJNINI OZNAKA - STEKLENIČKA S 30 TABLETAMI
If a dose of 0.4 g is to be administered, please use the dedicated 0.8 g powder presentation with dosing spoon. 
Če je treba vzeti 0,4 g odmerek, prosimo uporabite temu namenjeno 0,8 g obliko praška z odmerno žličko.
Dialysis 
Odmerjanje
Microcrystalline cellulose Sodium chloride Zinc stearate 
FARMACEVTSKI PODATKI 6.1 Seznam pomožnih snovi Jedro tablete: mikrokristalna celuloza natrijev klorid cinkov stearat
For a 0.4 g dose: o Shake the sachet holding the top corner before opening, to move the powder to the bottom of the sachet o Open the sachet by tearing along the marked line. 
Uporabite priloženo odmerno žličko za vsak 0,4 g odmerek praška zdravila Sevelamerijev karbonat Winthrop Za odmerek 0,4 g: o Stresite vrečico tako, da jo pred odprtjem držite za zgornji vogal, da se prašek premakne na dno vrečice.
Packs of 1 bottle of 30 tablets or bottles of 180 tablets without outer carton. 
Pakiranja z 1 vsebnikom, ki vsebuje 30 tablet ali z vsebnikom, ki vsebuje 180 tablet brez zunanje škatle.
EU/1/14/952/005 90 sachets EU/1/14/952/006 90 sachets (with a dosing spoon) 
EU/1/14/952/006 90 vrečic (z odmerno žličko)
He will base the dose on your serum phosphorus level. 
Zdravnik bo odmerek določil glede na koncentracijo fosfata v serumu.
The second study demonstrated that sevelamer carbonate powder dosed three times per day was equivalent to sevelamer hydrochloride tablets dosed three times per day in 31 hyperphosphataemic (defined as serum phosphorus levels ≥ 1.78 mmol/L) haemodialysis patients over two randomised 4 week treatment periods (mean serum phosphorus time-weighted averages were 1.6 ± 0.5 mmol/L for sevelamer carbonate powder and 1.7 ± 0.4 mmol/L for sevelamer hydrochloride tablets). 
Druga študija je pokazala, da so bili trije dnevni odmerki praška sevelamerijevega karbonata enakovredni trem dnevnim odmerkom tablet sevelamerijevega klorida pri 31 bolnikih s hiperfosfatemijo na hemodializi (opredeljeno kot ravni fosforja v serumu ≥ 1,78 mmol/l), zdravljenih v dveh naključnih 4-tedenskih obdobjih (srednje časovno uteženo povprečje fosforja v serumu je bilo 1,6 ± 0,5 mmol/l za prašek sevelamerijevega karbonata in 1,7 ± 0,4 mmol/l za tablete sevelamerijevega klorida).
Powder for oral suspension 2.4 g powder 
FARMACEVTSKA OBLIKA IN VSEBINA prašek za peroralno suspenzijo 2,4 g praška
This medicine should be used with other treatments such as calcium supplements and vitamin D to prevent the development of bone disease. 
To zdravilo se sme uporabljati sočasno s terapijo preventive razvoja bolezni kosti pri kateri se dodaja kalcij in vitamin D.
Difficulties swallowing the Sevelamer carbonate Winthrop tablet have been reported. 
Poročali so o težavah s požiranjem tablet Sevelamerijev karbonat Winthrop.
The safety and efficacy of Sevelamer carbonate Winthrop in children below the age of 6 years or in children with a BSA (Body Surface Area) below 0.75 m2 have not been established. 
Varnost in učinkovitost zdravila Sevelamerijev karbonat Winthrop pri otrocih, mlajših od 6 let, niti pri otrocih s telesno površino manj kot 0,75 m2 nista ugotovljeni.
EU/1/14/952/002 60 sachets EU/1/14/952/003 90 sachets 
EU/1/14/952/003 90 vrečic
How to store Sevelamer carbonate Winthrop 6. 
Shranjevanje zdravila Sevelamer carbonate Winthrop 6.